## Key Points 1. The goal of liver transplantation is not only to ensure the survival of patients but also to offer patients the opportunity to achieve a good balance between the functional efficacy of the graft and their psychological and physical integrity. The quality of life after transplantati
Post-liver transplantation myocardial dysfunction
β Scribed by Sampathkumar, Priya ;Lerman, Amir ;Kim, Barbara Youngmee ;Narr, Bradley J. ;Poterucha, John J. ;Torsher, Laurence C. ;Plevak, David J.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1998
- Tongue
- English
- Weight
- 60 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
β¦ Synopsis
Patients with end-stage liver disease usually show a hyperdynamic circulatory state. It has previously been reported that patients who develop myocardial depression in the early post-liver transplantation period are more prone to organ failure and death. We reviewed the records of 754 adult patients undergoing liver transplantation at our institution and identified 7 patients who initially showed hyperdynamic circulation, but then developed reversible dilated cardiomyopathy in the early posttransplantation period. All identifiable causes of cardiac dysfunction, such as myocardial ischemia, thyroid dysfunction, and electrolyte imbalances, were excluded. Left ventricular ejection fraction decreased from a preoperative median baseline of 60% to 20% (P β«Ψβ¬ .02), with four-chamber dilatation on echocardiogram. All these patients required supportive care, including mechanical ventilation, afterload reduction, inotropic support, and monitoring in the intensive care unit. Cardiac function subsequently improved in all patients, with ejection fraction increasing to a median of 50%. All patients were discharged from the hospital. At a median follow-up of 15 months, there was no recurrence of heart failure. The increased peripheral resistance seen after successful liver transplantation may be an important causative factor.
π SIMILAR VOLUMES
## Key Points 1. Pretransplant kidney function is an important predictor of posttransplant kidney function. 2. Chronic kidney disease is present in 20% of liver transplant recipients by 5 years. 3. Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndro
Anemia is common after liver transplantation, with the incidence ranging from 4.3% to 28.2% depending on the criteria used to define anemia. The cause of anemia is unidentified in the majority of patients, and it is likely to be multifactorial. Immunosuppressive-medication-induced bone marrow suppre
Anxiety is a common experience in chronic illness but for many with end-stage liver disease it is also associated with the stress of waiting for a donor organ to become available. Quality of life, work, family and social roles are all impaired and these losses may also contribute to depression. This
The model for end-stage liver disease (MELD) was developed to predict short-term mortality in patients with cirrhosis. It has since become the standard tool to prioritize patients for liver transplantation. We assessed the value of pretransplant MELD in the prediction of posttransplant survival. We
I read with interest the two case reports 1,2 and editorial 3 on recurrence of nonalcoholic steatohepatitis (NASH) post-liver transplantation. Many of the interesting points were well made. However, I was amazed that there was no discussion about the possibility that neither of the 2 patients actual